Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MED1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
BMP2K - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF566 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SGPL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DNAJC21 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC30A6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CCDC127 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM122C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
DDX6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NUBP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HSPA6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KIZ - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RAD51B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ASPH - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KANSL1-AS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM161A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
VIM - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LRRFIP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PARP11 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CLK1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on